Corpus Intelligence IC Memo — MODOC MEDICAL CENTER 2026-04-26 15:55 UTC
IC Memo — MODOC MEDICAL CENTER
Investment Committee Memorandum | CA | 8 beds | Grade C | EBITDA uplift $2.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MODOC MEDICAL CENTER

CCN 051330 | nan, CA | 8 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MODOC MEDICAL CENTER is a 8-bed community hospital in nan, CA with $39.0M in net patient revenue and a -1.0% operating margin. The hospital serves a payer mix of 69.5% Medicare, 0.0% Medicaid, and 30.5% commercial.

Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.0% to 6.3% (+736bps).

Net Revenue HCRIS$39.0M
Current EBITDA COMPUTED$-406K
Operating Margin COMPUTED-1.0%
Occupancy HCRIS54.1%
Revenue / Bed COMPUTED$4.9M
Net-to-Gross HCRIS78.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
16
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -1.0% places it above the state median. Among 16 size-comparable peers (4-16 beds), the median margin is -15.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (4-16), prioritizing same-state peers. 16 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MODOC MEDICAL CENTER (Target)CA8$39.0M-1.0%
JEWISH HOME FOR THE AGEDCA13$88.0M-48.0%
MEE MEMORIAL HOSPITALCA13$67.6M3.3%
JOYCE EISENBERG KEEFER MEDICALCA10$52.9M18.8%
MAYERS MEMORIAL HOSPITALCA16$41.7M-1.3%
WEST COVINA MEDICAL CENTERCA13$40.6M55.3%
MEE MEMORIAL HOSPITALCA13$36.3M-23.4%
PLUMAS DISTRICT HOSPITAL CAHCA14$35.6M-18.0%
MOTION PICTURE AND TELEVISION CA12$31.8M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$819K+210bp18mo
Cost to Collect4.5%2.5%$780K+200bp12mo
Denial Rate Reduction12.0%6.5%$772K+198bp12mo
A/R Days Reduction5200.0%3800.0%$475K+122bp9mo
Clean Claim Rate88.0%96.0%$25K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$819K
Cost to Collect
$780K
Denial Rate Reduction
$772K
A/R Days Reduction
$475K
Clean Claim Rate
$25K
Total EBITDA Uplift$2.9M
Current EBITDA$-406K
+ RCM Uplift+$2.9M
Pro Forma EBITDA$2.5M
Current Margin-1.0%
Pro Forma Margin6.3%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-625K$26.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-625K$28.4M0.00x-100.0%
Bull Case9.0x11.0x$-562K$37.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-562K$41.0M0.00x-100.0%
Bear Case11.0x10.0x$-687K$11.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-687K$12.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 69.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 16 hospitals with 4-16 beds
  • Same-state prioritization (n=24)
  • Comp margins: P25=-50.0% / P50=-15.2% / P75=3.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.